Profusa entered into an Option Agreement on Jul 31 2026 to acquire 100% of G3 Vision Labs, which owns Med Screen Laboratories, Dominion Diagnostics and Acutis Diagnostics. Exercising the call option requires at least $30 million of new financing, debt consents or repayment at G3, stockholder approv…
BERKELEY, Calif., July 27, 2026 (GLOBE NEWSWIRE) -- Profusa, Inc. NASDAQ:PFSA, a digital health company pioneering next-generation biosensing technologies, announces the signing of a non-binding term sheet with a privately held, commercial-stage health diagnostics and toxicology testing company (th…
Profusa Inc NASDAQ:PFSA:
Shares of Profusa (PFSA) hit a record low on Thursday, crashing 28% after the biotech company announced its second reverse stock split of the year.Profusa said it will implement a 1-for-25 reverse stock split, effective July 7, 2026. The company's shares will continue trading under the same ticker…
BERKELEY, California, July 02, 2026 (GLOBE NEWSWIRE) -- Profusa, Inc. (“Profusa” or the “Company”) NASDAQ:PFSA, a commercial stage digital health company pioneering a next-generation technology platform enabling the continuous monitoring of an individual’s biochemistry, today announced that it filed…
